Skip to content

Clinical trials

Observational Multiple Myeloma trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Observational Country / region: France Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20104
20111
20125
20141
20156
20163
20174
20185
20193
20205
20214
20227
20234
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Recruiting12
Unknown status8
Active, not recruiting4
Not yet recruiting3
Terminated3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris8
Centre Hospitalier Universitaire de Saint Etienne3
Intergroupe Francophone du Myelome3
University Hospital, Toulouse3
BIWAKO2
Bristol-Myers Squibb2
Celgene2
Centre Hospitalier Universitaire, Amiens2
Hospices Civils de Lyon2
Institut Paoli-Calmettes2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma60
Monoclonal Gammopathy of Undetermined Significance4
Neoplasms4
Breast Neoplasms3
Lymphoma3
Neoplasms, Plasma Cell3
Hematologic Neoplasms2
Hodgkin Disease2
Leukemia2
Leukemia, Lymphocytic, Chronic, B-Cell2

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.